英文名稱 |
中文名稱 |
CAS號 |
操作 |
9,11-Eplerenone Impurity |
9,11-依普利酮烯酯雜質(zhì) |
95716-70-4 |
詳細(xì)
|
Apixaban |
阿哌沙班 |
503612-47-3 |
詳細(xì)
|
Apixaban Chloro Impurity |
阿哌沙班氯代雜質(zhì) |
1801881-20-8 |
詳細(xì)
|
Apixaban Ethyl ester Impurity |
阿哌沙班乙酯雜質(zhì) |
503614-91-3 |
詳細(xì)
|
Apixaban Impurity A (BMS-591455-01) |
阿哌沙班雜質(zhì)A |
503614-92-4 |
詳細(xì)
|
Apixaban Impurity H |
阿哌沙班雜質(zhì)H |
545445-44-1 |
詳細(xì)
|
Bortezomib |
硼替佐米 |
179324-69-7 |
詳細(xì)
|
Bortezomib D-phenylalanyl analog Impurity |
硼替佐米 D-苯丙酰胺雜質(zhì) |
|
詳細(xì)
|
Bortezomib Impurity B |
硼替佐米雜質(zhì)B |
114457-94-2 |
詳細(xì)
|
Bortezomib Impurity F |
硼替佐米雜質(zhì)F |
|
詳細(xì)
|
Bortezomib Intermediate A |
硼替佐米中間體A |
179324-87-9 |
詳細(xì)
|
Bortezomib L-phenylalanyl analog Impurity |
硼替佐米 L-苯丙酰胺雜質(zhì) |
|
詳細(xì)
|
Bortezomib PS-619 Impurity |
硼替佐米PS-619雜質(zhì) |
|
詳細(xì)
|
Canrenone |
坎利酮 |
976-71-6 |
詳細(xì)
|
Cefotetan Disodium |
頭孢替坦二鈉 |
74356-00-6 |
詳細(xì)
|
Cefotetan Disodium S-Oxide Impurity |
頭孢替坦二鈉-S-氧化雜質(zhì) |
|
詳細(xì)
|
Clevidipine 3,5-DiMethyl Ester Impurity |
非洛地平EP雜質(zhì)B |
91189-59-2 |
詳細(xì)
|
Clevidipine butyrate |
丁酸氯維地平 |
167221-71-8 |
詳細(xì)
|
Clevidipine Butyrate Ethyl Ester Impurity |
丁酸氯維地平乙酯雜質(zhì) |
|
詳細(xì)
|
Clevidipine Butyrate Impurity A |
丁酸氯維地平雜質(zhì)A |
123853-39-4 |
詳細(xì)
|
Clevidipine Butyrate Impurity E |
丁酸氯維地平雜質(zhì)E |
253597-19-2 |
詳細(xì)
|
Clevidipine Butyrate Impurity H168/79 |
丁酸氯維地平雜質(zhì)H168/79 |
253597-20-5 |
詳細(xì)
|
Clevidipine Butyrate Impurity H207/59 |
丁酸氯維地平雜質(zhì)H207/59 |
105383-68-4 |
詳細(xì)
|
Clevidipine Butyrate Impurity I |
丁酸氯維地平雜質(zhì)I |
138279-32-0 |
詳細(xì)
|
Clevidipine Butyrate Impurity J |
丁酸氯維地平雜質(zhì)J |
175688-79-6 |
詳細(xì)
|
Dabigatran etexilate |
達(dá)比加群酯 |
211915-06-9 |
詳細(xì)
|
Dabigatran etexilate mesylate |
甲磺酸達(dá)比加群酯 |
872728-81-9 |
詳細(xì)
|
Dabigatran Impurity A |
達(dá)比加群酯雜質(zhì)A |
1642853-67-5 |
詳細(xì)
|
Dabigatran Impurity B |
達(dá)比加群酯雜質(zhì)B |
1456889-80-7 |
詳細(xì)
|
Dabigatran Impurity C |
達(dá)比加群酯雜質(zhì)C |
1408238-36-7 |
詳細(xì)
|
Dabigatran Impurity D |
達(dá)比加群酯雜質(zhì)D |
1422435-40-2 |
詳細(xì)
|
Dabigatran Impurity E |
達(dá)比加群酯雜質(zhì)E |
1415506-19-2 |
詳細(xì)
|
Dabigatran Impurity F |
達(dá)比加群酯雜質(zhì)F |
1422435-41-3 |
詳細(xì)
|
Dabigatran Impurity H |
達(dá)比加群酯雜質(zhì)H |
1422495-93-9 |
詳細(xì)
|
Dabigatran Impurity I |
達(dá)比加群酯雜質(zhì)I |
1422435-35-5 |
詳細(xì)
|
Dabigatran Impurity J |
達(dá)比加群酯雜質(zhì)J |
1580491-16-2 |
詳細(xì)
|
Dabigatran Impurity K |
達(dá)比加群酯雜質(zhì)K |
1408238-40-3 |
詳細(xì)
|
Dabigatran Impurity L |
達(dá)比加群酯雜質(zhì)L |
211915-00-3 |
詳細(xì)
|
Dabigatran Impurity O |
達(dá)比加群酯雜質(zhì)O |
1349500-09-9 |
詳細(xì)
|
Dabigatran Impurity P |
達(dá)比加群酯雜質(zhì)P |
|
詳細(xì)
|
Dabigatran Impurity R |
達(dá)比加群酯雜質(zhì)R |
1610758-20-7 |
詳細(xì)
|
Dabigatran Impurity S |
達(dá)比加群酯雜質(zhì)S |
1415901-84-6 |
詳細(xì)
|
Desphenyl Tenofovir Alafenamide Impurity |
替諾福韋艾拉酚胺脫苯基雜質(zhì) |
851456-00-3 |
詳細(xì)
|
Edaravone P1 Impurity |
依達(dá)拉奉P1雜質(zhì) |
1357477-99-6 |
詳細(xì)
|
Edaravone P3 Impurity |
依達(dá)拉奉P3雜質(zhì) |
1323485-71-7 |
詳細(xì)
|
Edaravone Hydroxymethyl Impurity |
依達(dá)拉奉羥甲基雜質(zhì) |
1242471-40-4 |
詳細(xì)
|
Edaravone TriMer Impurity |
依達(dá)拉奉三聚體雜質(zhì) |
124009-63-8 |
詳細(xì)
|
Eplerenone |
依普利酮 |
107724-20-9 |
詳細(xì)
|
Eplerenone 7-Carboxylic Acid Impurity |
依普利酮-7-羧酸雜質(zhì) |
209253-82-7 |
詳細(xì)
|
Eplerenone 9,11-Dihydro Impurity |
依普利酮-9,11-二氫雜質(zhì) |
41020-65-9 |
詳細(xì)
|
Eplerenone Hydroxyacid Potassium Salt |
依普利酮羥基酸鉀鹽 |
95716-98-6 |
詳細(xì)
|
Methyl pyridine-4-carboxylate N-oxide |
甲基異煙酸-N-氧化物 |
3783-38-8 |
詳細(xì)
|
Quetiapine EP Impurity A |
喹硫平EP雜質(zhì)A |
844639-07-2 |
詳細(xì)
|
Quetiapine EP Impurity B |
喹硫平EP雜質(zhì)B |
111974-74-4 |
詳細(xì)
|
Quetiapine EP Impurity C |
喹硫平EP雜質(zhì)C |
1798840-31-9 |
詳細(xì)
|
Quetiapine EP Impurity E |
喹硫平EP雜質(zhì)E |
1371638-05-9 |
詳細(xì)
|
Quetiapine EP Impurity G |
喹硫平EP雜質(zhì)G |
3159-07-7 |
詳細(xì)
|
Quetiapine EP Impurity J |
喹硫平EP雜質(zhì)J |
329216-69-5 |
詳細(xì)
|
Quetiapine EP Impurity L |
喹硫平EP雜質(zhì)L |
1371638-11-7 |
詳細(xì)
|
Quetiapine EP Impurity N |
喹硫平EP雜質(zhì)N |
1800291-86-4 |
詳細(xì)
|
Quetiapine EP Impurity T |
喹硫平EP雜質(zhì)T |
5747-46-6 |
詳細(xì)
|
Quetiapine EP Impurity U |
喹硫平EP雜質(zhì)U |
5786-26-5 |
詳細(xì)
|
Quetiapine EP Impurity V |
喹硫平EP雜質(zhì)V |
2204369-14-0 |
詳細(xì)
|
Quetiapine fumarate |
富馬酸喹硫平 |
111974-72-2 |
詳細(xì)
|
Rivaroxaban |
利伐沙班 |
366789-02-8 |
詳細(xì)
|
Rivaroxaban AcetaMide Impurity |
利伐沙班乙酰胺雜質(zhì) |
1429334-00-8 |
詳細(xì)
|
Rivaroxaban BenzenedicarboxaMide Impurity |
利伐沙班苯二甲酰胺雜質(zhì) |
1365267-36-2 |
詳細(xì)
|
Rivaroxaban Dechloro Impurity |
利伐沙班脫氯雜質(zhì) |
1415566-28-7 |
詳細(xì)
|
Rivaroxaban Diamine Impurity |
利伐沙班二胺雜質(zhì) |
|
詳細(xì)
|
Rivaroxaban Dichloro Impurity |
利伐沙班二氯雜質(zhì) |
1770812-37-7 |
詳細(xì)
|
Rivaroxaban Impurity K |
利伐沙班雜質(zhì)K |
898543-06-1 |
詳細(xì)
|
Rivaroxaban Impurity L |
利伐沙班雜質(zhì)L |
446292-04-2 |
詳細(xì)
|
Rivaroxaban Impurity M |
利伐沙班雜質(zhì)M |
181140-34-1 |
詳細(xì)
|
Rivaroxaban Impurity N |
利伐沙班雜質(zhì)N |
24065-33-6 |
詳細(xì)
|
Rivaroxaban Impurity O |
利伐沙班雜質(zhì)O |
527-72-0 |
詳細(xì)
|
Rivaroxaban Impurity P |
利伐沙班雜質(zhì)P |
31166-29-7 |
詳細(xì)
|
Rivaroxaban Phthalimido Descarbonyl Impurity |
利伐沙班脫羰基雜質(zhì) |
446292-07-5 |
詳細(xì)
|
Rivaroxaban Phthalimido Impurity |
利伐沙班鄰苯二甲酰亞胺雜質(zhì) |
446292-08-6 |
詳細(xì)
|
Rivaroxaban Triamine Impurity |
利伐沙班三胺雜質(zhì) |
|
詳細(xì)
|
(S)-(+)-GLYCIDYL PHTHALIMIDE |
(S)-N-縮水甘油鄰苯二甲酰亞胺 |
161596-47-0 |
詳細(xì)
|
11α-HydroxEplerenone Impurity |
11α-羥基依普利酮雜質(zhì) |
192704-56-6 |
詳細(xì)
|
11α-Hydroxycarvenone |
11α-羥基坎利酮 |
192569-17-8 |
詳細(xì)
|
4-(4-Aminophenyl)morpholin-3-one |
4-(4-氨基苯基)嗎啡啉-3-酮 |
438056-69-0 |
詳細(xì)
|
7β-9,11-Eplerenone Impurity |
7β-9,11-依普利酮烯酯雜質(zhì) |
|
詳細(xì)
|
Tenofovir Alafenamide |
替諾福韋艾拉酚胺 |
379270-37-8 |
詳細(xì)
|
Bortezomib Amide Impurity |
硼替佐米酰胺雜質(zhì) |
289472-80-6 |
詳細(xì)
|
Apixaban Methyl ester Impurity(BMS-719288-01) |
阿哌沙班甲酯雜質(zhì) |
1074365-84-6 |
詳細(xì)
|
Bortezomib Impurity E |
硼替佐米雜質(zhì)E |
1132709-14-8 |
詳細(xì)
|
Quetiapine EP Impurity I |
喹硫平EP雜質(zhì)I |
329216-67-3 |
詳細(xì)
|
7β-Eplerenone Impurity |
7β-依普利酮雜質(zhì) |
209253-81-6 |
詳細(xì)
|
(1S,2R)-Bortezomib Impurity |
(1S,2R)-硼替佐米雜質(zhì) |
1132709-16-0 |
詳細(xì)
|
(1R,2R)-Bortezomib Impurity |
(1R,2R)-硼替佐米雜質(zhì) |
1132709-15-9 |
詳細(xì)
|
Rivaroxaban Urea Dimer Impurity |
利伐沙班尿素二聚體雜質(zhì) |
1365267-35-1 |
詳細(xì)
|
Rivaroxaban R-Isomer Impurity |
利伐沙班R-異構(gòu)體雜質(zhì) |
865479-71-6 |
詳細(xì)
|
Quetiapine EP Impurity W |
喹硫平EP雜質(zhì)W |
1800608-95-0 |
詳細(xì)
|
Quetiapine EP Impurity P |
喹硫平EP雜質(zhì)P |
1011758-03-4 |
詳細(xì)
|
Quetiapine EP Impurity H |
喹硫平EP雜質(zhì)H |
1076199-40-0 |
詳細(xì)
|
Quetiapine EP Impurity D |
喹硫平EP雜質(zhì)D |
945668-94-0 |
詳細(xì)
|
Dabigatran Impurity Q |
達(dá)比加群酯雜質(zhì)Q |
1610758-22-9 |
詳細(xì)
|
Clevidipine Butyrate Impurity H324/78 |
丁酸氯維地平雜質(zhì)H324/78 |
188649-48-1 |
詳細(xì)
|